The revenue stands at ₹2,820.47 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.30 per cent from ₹2,580.45 crore. This corresponds to a year-on-year *(YoY) growth of 24.26 per cent.
Operating Profit stands at ₹587.84 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.39 per cent from ₹532.50 crore. This corresponds to a year-on-year *(YoY) growth of 23.63 per cent.
PBDT stands at ₹555.52 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.43 per cent from ₹503.03 crore. This corresponds to a year-on-year *(YoY) growth of 24.54 per cent.
Profit Before Tax stands at ₹445.86 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.30 per cent from ₹393.52 crore. This corresponds to a year-on-year *(YoY) growth of 30.59 per cent.
Net Profit stands at ₹325.07 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.14 per cent from ₹292.49 crore. This represents a 29.32 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Emcure Pharma | -0.40% | 0.45% | 32.16% | 23.13% | 36.23% | 70.27% |
| Anthem Bioscienc | -0.37% | -1.24% | 14.64% | 5.12% | 17.76% | 44.16% |
| Ipca Labs. | -1.44% | -3.62% | 0.94% | -3.79% | 10.75% | 26.71% |
| Glaxosmi. Pharma | 1.24% | 0.72% | 7.42% | -11.85% | 11.95% | 6.19% |
| Ajanta Pharma | -0.68% | 0.23% | 0.88% | -10.11% | 2.59% | 32.33% |
| Sai Life | -2.50% | -7.85% | 25.61% | 23.40% | 55.94% | 102.97% |
| Wockhardt | 0.24% | -2.29% | 5.39% | 10.08% | 23.86% | 51.01% |
Whole Time Director : MUKUND KESHAO GURJAR
CMD & CEO : SATISH RAMANLAL MEHTA
Whole-time Director : NAMITA VIKAS THAPAR
Whole Time Director & COO : SAMIT SATISH MEHTA
Independent Director : Vidya Rajiv Yeravdekar
Independent Director : Vijay Gokhale
Independent Director : Shailesh Ayyangar
Non Executive Director : Samonnoi Banerjee
Company Sec. & Compli. Officer : Amruta Jana Yangalwar
Additional Director : RAMAN PILLAI RAGHU KUMAR